1887

Abstract

Resistance to azole antifungal agents in can be mediated by multidrug efflux transporters. In a previous study, we identified at least two such transporters, Cdr1p and Benp, which belong to the class of TP-inding assette (ABC) transporters and of major facilitators, respectively. To isolate additional factors potentially responsible for resistance to azole antifungal agents in the hypersusceptibility of a multidrug transporter mutant, δ, to these agents was complemented with a genomic library. Several new genes were isolated, one of which was a new ABC transporter gene called ( rug esistance). The protein Cdr2p encoded by this gene exhibited 84% identity with Cdr1p and could confer resistance to azole antifungal agents, to other antifungals (terbinafine, amorolfine) and to a variety of metabolic inhibitors. The disruption of in the strain CAF4-2 did not render cells more susceptible to these substances. When the disruption of was performed in the background of a mutant in which was deleted, the resulting double δ δ mutant was more susceptible to these agents than the single δ mutant. The absence of hypersusceptibility of the single δ mutant could be explained by the absence of mRNA in azole-susceptible strains. was overexpressed, however, in clinical isolates resistant to azole antifungal agents as described previously for but to levels exceeding or equal to those reached by Interestingly, expression was restored in δ mutants reverting spontaneously to wild-type levels of susceptibility to azole antifungal agents. These data demonstrate that plays an important role in mediating the resistance of to azole antifungal agents.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-143-2-405
1997-02-01
2021-05-16
Loading full text...

Full text loading...

/deliver/fulltext/micro/143/2/mic-143-2-405.html?itemId=/content/journal/micro/10.1099/00221287-143-2-405&mimeType=html&fmt=ahah

References

  1. Balzi E., Wang M., Leterme S., Van Dyck L., Goffeau A. 1994; PDR5, a novel yeast multidrug resistance transporter controlled by the transcription regulator PDR1.. J Biol Chem 269:2206–2214
    [Google Scholar]
  2. Berrouane Y.F., Hollis R.J., Pfaller M.A. 1996; Strain variation among and antifungal susceptibilities of isolates of Candida krusei.. J Clin Microbiol 34:1856–1858
    [Google Scholar]
  3. Bissinger P.H., Kuchler K. 1994; Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance.. J Biol Chem 269:4180–4186
    [Google Scholar]
  4. Chavanet P., Lopez J., Grappin M., Bonnin A., Duong M., Waldner A., Buisson M., Camerlynck P., Portier H. 1994; Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro in vivo correlation in HIV-infected patients.. AIDS 8:945–950
    [Google Scholar]
  5. Chen W., Struhl K. 1988; Saturation mutagenesis of a yeast bis3 “TATA element”: genetic evidence for a specific TATA-binding protein.. Proc Natl Acad Sci USA 852691–2695
    [Google Scholar]
  6. Ehrenhofer M.A., Wurgler F.E., Sengstag C. 1994; The Saccharomyces cerevisiae SGE1 gene product: a novel drug-resistance protein within the major facilitator superfamily.. Mol Gen Genet 244:287–294
    [Google Scholar]
  7. Essayag S.M., Baily G.G., Denning D.W., Burnie J.P. 1996; Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua.. Int J Syst Bacterial 46:35–40
    [Google Scholar]
  8. Feinberg A., Vogelstein B. 1984; A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity.. Anal Biochem 17:266–267
    [Google Scholar]
  9. Fling M.E., Kopf J., Tamarkin A., Gorman J.A., Smith H.A., Koltin Y. 1991; Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate.. Mol Gen Genet 227:318–329
    [Google Scholar]
  10. Fonzi W.A., Irwin M.Y. 1993; Isogenic strain construction and gene mapping in Candida albicans.. Genetics 134:717–728
    [Google Scholar]
  11. Goldway M., Teff D., Schmidt R., Oppenheim A.B., Koltin Y. 1995; Multidrug resistance in Candida albicans - disruption of the BENr gene.. Antimicrob Agents Chemother 39:422–426
    [Google Scholar]
  12. Hanahan D. 1985; Techniques for transformation of E. coli.. In DNA Cloning: a Practical Approach pp. 109–135 Edited by Glover D.M. Oxford: IRL Press;
    [Google Scholar]
  13. Hitchcock C.A., Pye G.W., Troke P.F., Johnson E.M., Warnock D.W. 1993; Fluconazole resistance in Candida glabrata.. Antimicrob Agents Chemother 37:1962–1965
    [Google Scholar]
  14. Hube B., Monod M., Schofield D.A., Brown A.J.P., Gow N.A.R. 1994; Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans.. Mol Microbiol 14:87–99
    [Google Scholar]
  15. Johnson E.M., Davey K.G., Szekely A., Warnock D.W. 1995a; Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species.. J Antimicrob Chemother 36:787–793
    [Google Scholar]
  16. Johnson E.M., Warnock D.W., Luker J., Porter S.R., Scully C. 1995b; Emergence of azole drug resistance in Candida species fom HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.. J Antimicrob Chemother 35:103–114
    [Google Scholar]
  17. Marichal P., Vanden Bossche H. 1995; Mechanisms of resistance to azole antifungals.. Acta Biochim Pol 42:509–516
    [Google Scholar]
  18. Monod M., Togni G., Hube B., Sanglard D. 1994; Multiplicity of genes encoding secreted aspartic proteinases in Candida species.. Mol Microbiol 13:357–368
    [Google Scholar]
  19. Needleman S.B., Wunsch C.D. 1970; A general method applicable to the search of similarities in the amino acid sequence of two proteins.. J Mol Biol 48:443–453
    [Google Scholar]
  20. Odds F.C. 1996; Resistance of clinically important yeasts to antifungal agents.. Int J Antimicrob Agents 6:145–147
    [Google Scholar]
  21. Odds F.C., Schmid J., Soll D.R. 1990; Epidemiology of Candida infections in AIDS.. In Mycoses in AIDS Patients pp. 67–74 Edited by Vanden Bossche H., Mackenzie D. W. R., Cauwenberg G., Van Custem J., Drouhet E., Dupont B. New York: Plenum Press;
    [Google Scholar]
  22. Odds F.C., Dams G., Just G., Lewi P. 1996; Susceptibilities of Candida spp to antifungal agents visualized by two-dimensional scatterplots of relative growth.. Antimicrob Agents Chemother 40:588–594
    [Google Scholar]
  23. Parkinson T., Falconer D.J., Hitchcock C.A. 1995; Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata.. Antimicrob Agents Chemother 39:1696–1699
    [Google Scholar]
  24. Powderly W.G. 1994; Resistant candidiasis.. AZDS Res Hum Retroviruses 10:925–929
    [Google Scholar]
  25. Prasad R., Dewergifosse P., Goffeau A., Balzi E. 1995; Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals.. Curr Genet 27:320–329
    [Google Scholar]
  26. Rex J.H., Rinaldi M.G., Pfaller M.A. 1995; Resistance of Candida species to fluconazole.. Antimicrob Agents Chemother 39:1–8
    [Google Scholar]
  27. Sanglard D., Kuchler K., Ischer F., Pagani J.L., Monod M., Bille J. 1995; Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.. Antimicrob Agents Chemother 39:2378–2386
    [Google Scholar]
  28. Sanglard D., Ischer F., Monod M., Bille J. 1996; Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.. Antimicrob Agents Chemother 40:2300–2305
    [Google Scholar]
  29. Santos M., Tuite M.F. 1995; The CUG codon is decoded in vivo as serine and not leucine in Candida albicans.. Nucleic Acids Res 23:1481–1486
    [Google Scholar]
  30. Vanden Bossche H., Marichal P., Odds F., Lejeune L., Coene M.-C. 1992; Characterization of an azole-resistant Candida glabrata isolate.. Antimicrob Agents Chemother 36:2602–2610
    [Google Scholar]
  31. Vanden Bossche H.V., Warnock D.W., Dupont B., Kerridge D., Sengupta S., Improvisi L., Marichal P., Odds F.G, Provost F., Ronin O. 1994a; Mechanisms and clinical impact of antifungal drug resistance.. J Med Vet Mycol 32: (Suppl. 1) 189–202
    [Google Scholar]
  32. Vanden Bossche H., Marichal P., Odds F.C. 1994b; Molecular mechanisms of drug resistance in fungi.. Trends Microbiol 2:393–400
    [Google Scholar]
  33. Vuffray A., Durussel G, Boerlin P.F., Bille J., Glauser M.P., Chave J.P. 1994; Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.. AIDS 8:708–709
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-143-2-405
Loading
/content/journal/micro/10.1099/00221287-143-2-405
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error